Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.

Source:http://linkedlifedata.com/resource/pubmed/id/10900238

Download in:

View as

General Info

PMID
10900238